Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adverse drug reactions to antiretroviral medication.
Roca B. Roca B. Front Biosci (Landmark Ed). 2009 Jan 1;14:1785-92. doi: 10.2741/3340. Front Biosci (Landmark Ed). 2009. PMID: 19273162 Review.
Pharmacogenomics of antiretrovirals.
Roca B. Roca B. Recent Pat Antiinfect Drug Discov. 2008 Jun;3(2):132-5. doi: 10.2174/157489108784746650. Recent Pat Antiinfect Drug Discov. 2008. PMID: 18673126 Review.
Increasing knowledge about genes implicated in pharmacokinetics, mode of action, efficacy, and toxicity of drugs has already provided relevant results for clinical practice, for example: The strong association of the abacavir hypersensitivity reaction with HLA-B*5701 permi …
Increasing knowledge about genes implicated in pharmacokinetics, mode of action, efficacy, and toxicity of drugs has already provided releva …
[Pharmacogenomics of antiretrovirals].
Roca B. Roca B. Med Clin (Barc). 2009 Feb 28;132(7):268-71. doi: 10.1016/j.medcli.2008.10.032. Epub 2009 Feb 12. Med Clin (Barc). 2009. PMID: 19248878 Review. Spanish. No abstract available.
Castleman's Disease. A Review.
Roca B. Roca B. AIDS Rev. 2009 Jan-Mar;11(1):3-7. AIDS Rev. 2009. PMID: 19290029 Review.
Typhlitis as a complication of influenza in a patient with advanced HIV infection.
Roca B, Fernandez P, Roca M. Roca B, et al. Postgrad Med. 2018 Sep;130(7):650-651. doi: 10.1080/00325481.2018.1508984. Epub 2018 Aug 11. Postgrad Med. 2018. PMID: 30092166
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord. De Luca A, et al. J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465. Epub 2016 Jan 28. J Antimicrob Chemother. 2016. PMID: 26825119 Free PMC article.
HIV-1 subtype B-infected patients were used as the derivation dataset and HIV-1 non-B-infected patients were used as the validation dataset. ...CONCLUSIONS: A model with a new darunavir-weighted mutation score outperformed existing GISs in both B and non-B
HIV-1 subtype B-infected patients were used as the derivation dataset and HIV-1 non-B-infected patients were used as the valid …
Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
Estrada V, Geijo P, Fuentes-Ferrer M, Alcalde ML, Rodrigo M, Galindo MJ, Muñoz A, Domingo P, Ribera E, Cosín J, Viciana P, Lozano F, Terrón A, Vergara A, Teira R, Muñoz-Sánchez J, Roca B, Sánchez T, López-Aldeguer J, Deig E, Vidal F, Pedrol E, Castaño-Carracedo M, Puig T, Garrido M, Suárez-Lozano I. Estrada V, et al. BMC Womens Health. 2011 Aug 4;11:36. doi: 10.1186/1472-6874-11-36. BMC Womens Health. 2011. PMID: 21816091 Free PMC article. Clinical Trial.
Hepatitis C virus co-infection and sexual risk behaviour are associated with a high homocysteine serum level in HIV-infected patients.
Roca B, Bennasar M, Ferrero JA, del Monte MC, Resino E. Roca B, et al. Swiss Med Wkly. 2012 Jan 11;141:w13323. doi: 10.4414/smw.2011.13323. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22252925
HAART with didanosine once versus twice daily: adherence and efficacy.
Roca B, Lapuebla C, Vidal-Tegedor B. Roca B, et al. Int J Infect Dis. 2005 Jul;9(4):195-200. doi: 10.1016/j.ijid.2004.07.006. Epub 2005 Apr 25. Int J Infect Dis. 2005. PMID: 15964537
[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].
Reus S, Portilla J, Gimeno A, Sánchez-Payá J, García-Henarejos JA, Martínez-Madrid O, Usó J, Roca B, Galindo MJ, López-Aldeguer J. Reus S, et al. Enferm Infecc Microbiol Clin. 2004 Mar;22(3):142-9. doi: 10.1016/s0213-005x(04)73054-2. Enferm Infecc Microbiol Clin. 2004. PMID: 14987534 Spanish.
181 results
Jump to page
Feedback